Evidence map›Paper›PMID 25031220›Full record

ArticleJournal of psychopharmacology (Oxford, England)2014

Modulation of neuronal microcircuit activities within the medial prefrontal cortex by mGluR5 positive allosteric modulator.

Marie Pollard, Jose Manuel Bartolome, P Jeffrey Conn, Thomas Steckler, Hamdy Shaban

Open access · greenAbstract read
In one paragraph

Article in Journal of psychopharmacology (Oxford, England), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Marie PollardJanssen Pharmaceutica NV, Beerse, Belgium.
Jose Manuel BartolomeNeuroscience Medicinal Chemistry, Janssen Research & Development, Toledo, Spain.
P Jeffrey ConnDepartment of Pharmacology, and the Vanderbilt Center for Neuroscience Drug Discovery 2, Vanderbilt University Medical School, Nashville, TN, USA.
Thomas StecklerJanssen Pharmaceutica NV, Beerse, Belgium.
Hamdy ShabanJanssen Pharmaceutica NV, Beerse, Belgium hshaban@its.jnj.com.
Janssen (Belgium) · BEVanderbilt University · US

Funding

Functions of Metabotropic Glutamate Receptor SubtypesR37NS031373 · NINDS · VANDERBILT UNIVERSITY · PI CONN, P JEFFREY · 2014 to 2020
$3.5M
NINDS NIH HHS R37 NS031373
6 · The paper itself

Abstract

Suppressing anxiety and fear memory relies on bidirectional projections between the medial prefrontal cortex and the amygdala. Positive allosteric modulators of mGluR5 improve cognition in animal models of schizophrenia and retrieval of newly formed associations such as extinction of fear-conditioned behaviour. The increase in neuronal network activities of the medial prefrontal cortex is influenced by both mGluR1 and mGluR5; however, it is not well understood how they modulate network activities and downstream information processing. To map mGluR5-mediated network activity in relation to its emergence as a viable cognitive enhancer, we tested group I mGluR compounds on medial prefrontal cortex network activity via multi-electrode array neuronal spiking and whole-cell patch clamp recordings. Results indicate that mGluR5 activation promotes feed-forward inhibition that depends on recruitment of neuronal activity by carbachol-evoked up states. The rate of neuronal spiking activity under the influence of carbachol was reduced by the mGluR5 positive allosteric modulator, N-(1,3-Diphenyl-1H-pyrazolo-5-yl)-4-nitrobenzamide (VU-29), and enhanced by the mGluR5 negative allosteric modulator, 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine hydrochloride (MTEP). Spontaneous inhibitory post-synaptic currents were increased upon application of carbachol and in combination with VU-29. These results emphasize a bias towards tonic mGluR5-mediated inhibition that might serve as a signal-to-noise enhancer of sensory inputs projected from associated limbic areas onto the medial prefrontal cortex neuronal microcircuit.

Indexed as

Action PotentialsAllosteric RegulationAnimalsBenzamidesCarbacholDrug SynergismExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsInhibitory Postsynaptic PotentialsMaleMethoxyhydroxyphenylglycolNeural PathwaysPrefrontal CortexPyrazolesPyridinesRats3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine3,4-dihydroxyphenylglycolBenzamidesCarbacholExcitatory Amino Acid AgonistsExcitatory Amino Acid Antagonistsmetabotropic glutamate receptor type 1MethoxyhydroxyphenylglycolN-(1,3-diphenyl-1H-pyrazolo-5-yl)-4-nitrobenzamidePyrazolesPyridinesReceptor, Metabotropic Glutamate 5Receptors, Metabotropic GlutamateThiazolesCholinergic transmissioninhibitory postsynaptic currentsmetabotropic glutamate receptorsmulti-electrode recordingspositive allosteric modulator

Identifiers

PMID25031220
PMCPMC4356529
OpenAlexW2059298994

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.